Evidence map›Paper›PMID 34750520›Full record

ArticlePediatric research2022

Single-cell immunophenotyping of the fetal immune response to maternal SARS-CoV-2 infection in late gestation.

Juan D Matute, Benjamin Finander, David Pepin, Xingbin Ai, Neal P Smith, Jonathan Z Li, Andrea G Edlow, Alexandra-Chloe Villani, Paul H Lerou, Brian T Kalish

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Juan D MatuteDivision of Neonatology and Newborn Medicine, Department of Pediatrics, Massachusetts General Hospital (MGH), Boston, MA, USA. jmatute@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-1703-8115
Benjamin FinanderDivision of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
David PepinDepartment of Pediatric Surgery, MGH, Boston, MA, USA.
Xingbin AiDivision of Neonatology and Newborn Medicine, Department of Pediatrics, Massachusetts General Hospital (MGH), Boston, MA, USA.
Neal P SmithDepartment of Medicine, MGH, Boston, MA, USA.
Jonathan Z LiDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Andrea G EdlowDepartment of Obstetrics and Gynecology, MGH, Boston, MA, USA.
Alexandra-Chloe VillaniDepartment of Medicine, MGH, Boston, MA, USA.
Paul H LerouDivision of Neonatology and Newborn Medicine, Department of Pediatrics, Massachusetts General Hospital (MGH), Boston, MA, USA.
Brian T KalishDivision of Newborn Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA. brian.kalish@sickkids.ca.
MGH Institute of Health Professions · USMassachusetts General Hospital · USBoston Children's Hospital · USBrigham and Women's Hospital · US

Funding

Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
Sex Differences in Fetal Brain-Placental Immune Programming in Maternal ObesityR01HD100022 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI EDLOW, ANDREA GOLDBERG · 2019 to 2021
$2.0M
Activity-Dependent Regulation of the Neuronal EpigenomeK08NS112338 · NINDS · HARVARD MEDICAL SCHOOL · PI KALISH, BRIAN · 2020 to 2020
$196k
NIAID NIH HHS UM1 AI069412NICHD NIH HHS R01 HD100022NINDS NIH HHS K08 NS112338
6 · The paper itself

Abstract

backgroundDuring the COVID-19 pandemic, thousands of pregnant women have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The implications of maternal SARS-CoV-2 infection on fetal and childhood well-being need to be characterized. We aimed to characterize the fetal immune response to maternal SARS-CoV-2 infection.

methodsWe performed single-cell RNA-sequencing and T cell receptor sequencing on cord blood mononuclear cells (CBMCs) from newborns of mothers infected with SARS-CoV-2 in the third trimester (cases) or without SARS-CoV-2 infection (controls).

resultsWe identified widespread gene expression changes in CBMCs from cases, including upregulation of interferon-stimulated genes and major histocompatibility complex genes in CD14

conclusionsAs none of the infants were infected with SARS-CoV-2, our results suggest that maternal SARS-CoV-2 infection might modulate the fetal immune system in the absence of vertical transmission. IMPACT: The implications of maternal SARS-CoV-2 infection in the absence of vertical transmission on fetal and childhood well-being are poorly understood. Maternal SARS-CoV-2 infection might modulate the fetal immune system in the absence of vertical transmission. This study raises important questions about the untoward effects of maternal SARS-CoV-2 on the fetus, even in the absence of vertical transmission.

Indexed as

COVID-19Pregnancy Complications, InfectiousChildFemaleFetusHumansImmunityImmunophenotypingInfant, NewbornInfectious Disease Transmission, VerticalPandemicsPregnancySARS-CoV-2

Identifiers

PMID34750520
PMCPMC8573077
OpenAlexW3136372433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.